ReviewJournal of immunotherapy and precision oncology2026

The Immune Checkpoint Inhibitors Journey: From Early Promise to Lasting Impact.

Joud Hajjar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.